Prevalence and Clinical Characteristics of Vasculitis in the Alaska Native and American Indian Peoples of Alaska
Arthritis Care & Research · 2025
DOI: 10.1002/acr.25506 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis Care & Research, 2025. Verfasst von Ben A Henderson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Alaska Native Tribal Health Consortium, Anchorage, Alaska. Hauptthemen laut MEDLINE: Alaska Natives, American Indian or Alaska Native, Vasculitis, Indians, North American. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, National Institute on Minority Health and Health Disparities.
Abstract (Originalsprache)
Objective
Our objective was to determine the prevalence and clinical characteristics of vasculitis in Alaska Native and American Indian (AN/AI) peoples of Alaska.
Methods
We queried the electronic health records of participating tribal health organizations within the Alaska Tribal Health System (ATHS) to identify adults with diagnostic codes related to vasculitis. Medical record abstraction was performed for all adults with potential vasculitis to confirm fulfillment of inclusion criteria, subtype, and clinical characteristics. The denominator for prevalence was the 2019 ATHS user population ≥ 18 (except giant cell arteritis [GCA], defined for persons ≥ 50).
Results
The age‐adjusted prevalence per 1,000,000 AN/AI adults was 752 (95% confidence interval [CI] 581–959) for all vasculitis, with systemic vasculitis being the most common at 518 (95% CI 379–695). The most prevalent types of systemic vasculitis were antineutrophil cytoplasmic antibody–associated vasculitis (AAV) at 340 per million adults (95% CI 230–488) and GCA at 28 per 100,000 ≥ 50 (95% CI 12–56). The most prevalent subtype of AAV was granulomatosis with polyangiitis (GPA) at 244 per million adults (95% CI 148–380). AAV was diagnosed at a mean age of 54.2 years (SD 17), often with high markers of inflammation and renal involvement. GCA was diagnosed at a mean age of 69.6 years (SD 9.2).
Conclusion
The prevalence of AAV (especially GPA) in AN/AI peoples is high. GCA prevalence is lower than White populations, but higher than many other populations. AN/AI peoples with AAV and GCA may present at younger ages with more severe disease than other populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Alaska Native Tribal Health Consortium, Anchorage, Alaska.
ORCID-Profile: Elizabeth D Ferucci
Förderung
- NIMHD NIH HHS
- National Institute on Minority Health and Health Disparities
Zitieren
APA
Henderson, B. A., Mehta, V. R., Holck, P., Choromanski, T. L., Wilson, A., Lee, F., & Ferucci, E. D. (2025). Prevalence and Clinical Characteristics of Vasculitis in the Alaska Native and American Indian Peoples of Alaska. Arthritis Care & Research. https://doi.org/10.1002/acr.25506
Vancouver
Henderson BA, Mehta VR, Holck P, Choromanski TL, Wilson A, Lee F, et al. Prevalence and Clinical Characteristics of Vasculitis in the Alaska Native and American Indian Peoples of Alaska. Arthritis Care & Research. 2025. doi:10.1002/acr.25506
BibTeX
@article{Henderson2025,
author = {Henderson, Ben A and Mehta, Vivek R and Holck, Peter and Choromanski, Tammy L and Wilson, Amy and Lee, Flora and Ferucci, Elizabeth D},
title = {Prevalence and Clinical Characteristics of Vasculitis in the Alaska Native and American Indian Peoples of Alaska},
journal = {Arthritis Care & Research},
year = {2025},
doi = {10.1002/acr.25506}
}
EUVIMED